tiprankstipranks
4D Molecular Therapeutics, Inc. (FDMT)
:FDMT
US Market

4D Molecular Therapeutics (FDMT) Ownership - Who Owns 4D Molecular Therapeutics?

Compare
339 Followers

4D Molecular Therapeutics (FDMT) Ownership Overview

14.99%13.25%1.41%12.07%58.27%
14.99% Insiders
1.41% Other Institutional Investors
12.07% ETFs
58.27% Public Companies and Individual Investors
The ownership structure of 4D Molecular Therapeutics (FDMT) stock is a mix of institutional, retail, and individual investors. Approximately 26.74% of the company’s stock is owned by Institutional Investors, 14.99% is owned by Insiders, and 58.27% is owned by Public Companies and Individual Investors.
The ownership structure of 4D Molecular Therapeutics (FDMT) stock is a mix of institutional, retail, and individual investors. Approximately 14.67% of the company’s stock is owned by Institutional Investors, 14.99% is owned by Insiders, and 12.07% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$309352
Dec 31, 2024
xxxxxxxxxxxxx
$25417085

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,098,211Institution11.03%24,879,270
4,563,211Insider9.87%22,268,470
2,934,914Institution6.35%14,322,380
2,445,261Institution5.29%11,932,874
2,382,984Institution5.15%11,628,962
2,033,069Insider4.70%9,921,377
2,126,642Institution4.60%10,378,013
1,016,235Institution2.20%4,959,227
554,551Institution1.20%2,706,209
422,856Institution0.91%2,063,537

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,126,642Institution4.60%10,378,013
1,016,235Institution2.20%4,959,227
554,551Institution1.20%2,706,209
422,856Institution0.91%2,063,537
388,894Institution0.84%1,897,803
333,676Institution0.72%1,628,339
282,412Institution0.61%1,378,171
182,230Institution0.39%889,282
158,842Institution0.34%775,149
135,933Institution0.29%663,353

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,537,368Institution3.33%8,563,140
1,363,152Institution2.95%6,652,182
475,001Institution1.03%2,645,756
289,523Institution0.63%1,412,872
242,992Institution0.53%1,185,801
240,240Institution0.52%1,338,137
163,281Institution0.35%796,811
162,757Institution0.35%768,213
116,006Institution0.25%566,109
84,733Institution0.18%471,963

FAQ

Who Owns 4D Molecular Therapeutics, Inc. (FDMT)?
According to the latest TipRanks data, approximately 1.41% of the company's stock is held by institutional investors, 14.99% is held by insiders, and 58.27% is held by retail investors.
    What percentage of 4D Molecular Therapeutics, Inc. (FDMT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.41% of 4D Molecular Therapeutics, Inc. (FDMT) stock is held by institutional investors.
      What percentage of 4D Molecular Therapeutics, Inc. (FDMT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 58.27% of 4D Molecular Therapeutics, Inc. (FDMT) stock is held by retail investors.
        Who owns the most shares of 4D Molecular Therapeutics, Inc. (FDMT)?
        Peter Kolchinsky owns the most shares of 4D Molecular Therapeutics, Inc. (FDMT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis